A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)

Abstract Background In an oligometastatic setting, metastasis-directed treatment could render patients disease free, possibly for a protracted interval. Stereotactic ablative radiotherapy (SABR) is one of the treatment modalities that can be offered to these patients. In addition, the radiobiologica...

Full description

Bibliographic Details
Main Authors:	Carole Mercier, Piet Dirix, Paul Meijnders, Peter Vermeulen, Steven Van Laere, Hilde Debois, Philippe Huget, Dirk Verellen
Format:	Article
Language:	English
Published:	BMC 2018-08-01
Series:	Radiation Oncology
Subjects:	Stereotactic ablative radiotherapy Non-spine bone metastases Lymph node metastases
Online Access:	http://link.springer.com/article/10.1186/s13014-018-1096-9

Internet

http://link.springer.com/article/10.1186/s13014-018-1096-9

A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)

Internet

Similar Items